This research adds a new tool in the manufacturing toolbox for vaccines and other RNA based therapeutics. A conventional vaccine manufacturing plant requires several months and a significant multi-million pound investment to be built. There is therefore an urgent need for a dramatic and rapid increase in manufacturing capacity and this can be addressed with new thinking and technology that pushes convention and current boundaries. We work precisely to achieve that with research that combines flow technologies with computer control, delivers compact, reproducible manufacturing environments to make these therapeutics reliably and continuously, and ultimately at the point-of-use. The result is manufacturing capability that can scale rapidly to meet the needs of the population, reducing dependency on overseas supply and at a small fraction of the investment required for a typical biopharmaceutical plant.–
At King’s, Harris’ research interests include a focus on Artificial Intelligence for process automation, Circular Manufacturing Systems enabled by bioprocessing, and flow technologies for vaccines manufacturing.
On this recognition from the Royal Academy of Engineering, Professor Barbara Shollock - Head of the Department of Engineering - commented:
The President’s Special Award for Pandemic Service is just one way to highlight the diversity of contributions in this public health crisis. Engineering expertise, working alongside other disciplines, is key to developing innovative solutions, and Harris’s research is an excellent example of this. We at King’s College Department of Engineering are delighted that he has been recognised with this award–